These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 36442087)
1. Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia. Cheng WY; Li JF; Zhu YM; Lin XJ; Wen LJ; Zhang F; Zhang YL; Zhao M; Fang H; Wang SY; Lin XJ; Qiao N; Yin W; Zhang JN; Dai YT; Jiang L; Sun XJ; Xu Y; Zhang TT; Chen SN; Zhu HH; Chen Z; Jin J; Wu DP; Shen Y; Chen SJ Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2211429119. PubMed ID: 36442087 [TBL] [Abstract][Full Text] [Related]
2. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia. Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223 [TBL] [Abstract][Full Text] [Related]
4. Identification of IKZF1 genetic mutations as new molecular subtypes in acute myeloid leukaemia. Wang Y; Cheng W; Zhang Y; Zhang Y; Sun T; Zhu Y; Yin W; Zhang J; Li J; Shen Y Clin Transl Med; 2023 Jun; 13(6):e1309. PubMed ID: 37345307 [TBL] [Abstract][Full Text] [Related]
5. Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia. Vergez F; Largeaud L; Bertoli S; Nicolau ML; Rieu JB; Vergnolle I; Saland E; Sarry A; Tavitian S; Huguet F; Picard M; Vial JP; Lechevalier N; Bidet A; Dumas PY; Pigneux A; Luquet I; Mansat-De Mas V; Delabesse E; Carroll M; Danet-Desnoyers G; Sarry JE; Récher C Blood Cancer J; 2022 Aug; 12(8):117. PubMed ID: 35973983 [TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature. Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458 [TBL] [Abstract][Full Text] [Related]
7. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia. Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212 [TBL] [Abstract][Full Text] [Related]
8. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321 [TBL] [Abstract][Full Text] [Related]
9. Transcriptome Profiling of Pediatric Core Binding Factor AML. Hsu CH; Nguyen C; Yan C; Ries RE; Chen QR; Hu Y; Ostronoff F; Stirewalt DL; Komatsoulis G; Levy S; Meerzaman D; Meshinchi S PLoS One; 2015; 10(9):e0138782. PubMed ID: 26397705 [TBL] [Abstract][Full Text] [Related]
10. Aging and comprehensive molecular profiling in acute myeloid leukemia. Li JF; Cheng WY; Lin XJ; Wen LJ; Wang K; Zhu YM; Zhu HM; Chen XJ; Zhang YL; Yin W; Zhang JN; Yi X; Zhang F; Weng XQ; Wang SY; Jiang L; Wu HY; Ren JQ; Lin XJ; Qiao N; Dai YT; Fang H; Tan Y; Sun XJ; Lv G; Yan XY; Chen SN; Chen Z; Jin J; Wu DP; Ren RB; Chen SJ; Shen Y Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2319366121. PubMed ID: 38422020 [TBL] [Abstract][Full Text] [Related]
11. [Genetic aberrations and new treatment strategies for pediatric acute myeloid leukemia]. Shiba N Rinsho Ketsueki; 2018; 59(10):2260-2267. PubMed ID: 30305534 [TBL] [Abstract][Full Text] [Related]
12. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling. Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833 [TBL] [Abstract][Full Text] [Related]
13. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia. Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328 [TBL] [Abstract][Full Text] [Related]
14. Analytical study of Sepúlveda-Robles O; Jiménez-Hernández E; Domínguez-Catzín V; Gómez-Flores E; Martín-Trejo JA; Flores-Lujano J; Torres-Nava JR; Núñez-Enríquez JC; De Ita M; Medina-Sanson A; Mata-Rocha M; Morales-Castillo BA; Bravata-Alcántara JC; Nájera-Cortés AS; Sánchez-Escobar N; Peñaloza-Gonzalez JG; Espinosa-Elizondo RM; Flores-Villegas LV; Amador-Sanchez R; Orozco-Ruiz D; Pérez-Saldívar ML; Velázquez-Aviña MM; Merino-Pasaye LE; Solís-Labastida KA; González-Ávila AI; Santillán-Juárez JD; Bekker-Méndez VC; Jiménez-Morales S; Rangel-López A; Rosas-Vargas H; Mejía-Aranguré JM Front Pediatr; 2022; 10():946690. PubMed ID: 36452349 [TBL] [Abstract][Full Text] [Related]
15. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach. Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829 [TBL] [Abstract][Full Text] [Related]
16. A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia. Docking TR; Parker JDK; Jädersten M; Duns G; Chang L; Jiang J; Pilsworth JA; Swanson LA; Chan SK; Chiu R; Nip KM; Mar S; Mo A; Wang X; Martinez-Høyer S; Stubbins RJ; Mungall KL; Mungall AJ; Moore RA; Jones SJM; Birol İ; Marra MA; Hogge D; Karsan A Nat Commun; 2021 Apr; 12(1):2474. PubMed ID: 33931648 [TBL] [Abstract][Full Text] [Related]
17. The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes. Olsson L; Zettermark S; Biloglav A; Castor A; Behrendtz M; Forestier E; Paulsson K; Johansson B Br J Haematol; 2016 Jul; 174(2):292-301. PubMed ID: 27022003 [TBL] [Abstract][Full Text] [Related]
18. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia. Al-Kershi S; Bhayadia R; Ng M; Verboon L; Emmrich S; Gack L; Schwarzer A; Strowig T; Heckl D; Klusmann JH Blood Adv; 2019 Dec; 3(24):4252-4263. PubMed ID: 31867596 [TBL] [Abstract][Full Text] [Related]